Cronos Group Posts Another Gross Loss For Q2, Replaces CFO

Cronos Group (TSX: CRON) (NASDAQ: CRON) this morning reported their second quarter financial results. Revenues improved over the first quarter of 2021, with the company posting consolidated net revenue of $15.6 million for the quarter. Despite this, the company still managed to post gross losses, which grew on a quarterly basis.

Revenues for the quarter of $15.6 million were a significant improvement over the net revenue of $12.6 million reported in Q1, with results just barely making consensus estimates. Despite this, the company posted a larger gross loss, with the loss growing from $3.0 million in Q1 to $15.8 million in Q2 – a figure larger than consolidated net revenue itself. Gross margins as a result sat at -101%. The significant gross loss was a result of $12.0 million in inventory write-downs – which means that even before writedowns, the company is running at a gross loss, and that the business is entirely unsustainable.

Operating expenses grew on a quarterly basis as well, climbing to $44.4 million. The largest expense consisted of general and administrative, at $22.4 million, followed by sales and marketing at $13.2 million, and R&D at $5.2 million. Operating expenses as a whole effectively amounted to $2.84 per dollar of consolidated net revenue.

Despite the disastrous results, the company managed to post a net income, which is largely the function of a $115.2 million gain on the revaluation of derivative liabilities. The company managed to post a net income of $56.8 million as a result, while adjusted EBITDA came in at negative $49.8 million.

Also notable is the fact that the company has finally sunk below a billion dollars in cash and cash equivalents, which now sits at $895.2 million, down from $1.0 billion last quarter. Short term investments also declined, from $214.9 million to $201.7 million.

The company this morning also announced the appointment of Bob Madore as CFO, replacing Jerry Barbato. Reasoning for his departure was not provided.

Cronos Group last traded at $9.28 on the TSX.


Information for this briefing was found via Sedar and Cronos Group. The author has no securities or affiliations related to these organizations. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

Cronos Group: Canaccord, PI Reiterate Ratings, Adjust Revenue Estimates

Cronos Group (TSX: CRON) (NASDAQ: CRON) reported its second quarter financials on August 6 pre-market,...

Sunday, August 9, 2020, 04:20:00 PM

Is The Medipharm Labs Supply Arrangement The Source Of Cronos’ Late Filings?

Earlier this week, Cronos Group (TSX: CRON) (NASDAQ: CRON) quietly announced that they would delay...

Wednesday, March 4, 2020, 12:12:37 PM

Cronos Group, Ginkgo Bioworks Achieve Partnership Productivity Target For CBG Acid

Cronos Group, Inc. (TSX: CRON) and Ginkgo Bioworks announced this morning that its partnership has...

Monday, August 23, 2021, 10:38:00 AM

Did Cronos Group Management Personally Benefit from the Redwood Acquisition?

This morning, Twitter user @xb0y posted findings related to a potentially undisclosed insider transaction related...

Monday, September 9, 2019, 11:10:04 AM

SEC Charges Cronos Group With Accounting Fraud

Canadian cannabis company Cronos Group Inc (TSX: CRON) and its former senior executive were charged...

Monday, October 24, 2022, 05:52:17 PM